GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Stock
Total 13F shares
20,239,213
Share change
-2,164,911
Total reported value
$87,684,006
Put/Call ratio
0%
Price per share
$4.33
Number of holders
68
Value change
-$10,728,031
Number of buys
27
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GYRE THERAPEUTICS INC COM - Stock (CBIO) as of Q2 2021

As of 30 Jun 2021, GYRE THERAPEUTICS INC COM - Stock (CBIO) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,239,213 shares. The largest 10 holders included Stonepine Capital Management, LLC, Nantahala Capital Management, LLC, ORBIMED ADVISORS LLC, 22NW, LP, VANGUARD GROUP INC, Ghost Tree Capital, LLC, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, ACUTA CAPITAL PARTNERS, LLC, and Sio Capital Management, LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.